Product Information
METRONIDAZOLE 250 MG TABLET is a generic product labeled by Teva Pharmaceuticals USA Inc., priced at $0.1007 per EA under NDC 50111033302. Its NADAC has been published 657 times since Nov 28, 2013.
Strength
250 mg/1
Manufacturer
Teva Pharmaceuticals USA Inc.NDC
50111033302
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
METRONIDAZOLEApproval Type
Generic (ANDA)
FDA Application
ANDA070027On Market Since
9/30/1990
Pharmacological Classes
Price Statistics
The NADAC for METRONIDAZOLE 250 MG TABLET has been published 657 times since Nov 28, 2013, and over the history we have for it it has declined 63.7%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1007 per EA |
|---|---|
| All-time high | $0.2872 (Mar 12, 2014) |
| All-time low | $0.0623 (Dec 17, 2025) |
| 52-week high | $0.1096 |
| 52-week low | $0.0623 |
| Median price | $0.1506 |
| Average price | $0.1719 |
| Largest weekly change | +36.9% (May 22, 2019) |
| Weeks tracked | 657 |
| Tracking since | Nov 28, 2013 |
Generic Alternatives
The matcher finds 9 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 9 manufacturers (up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 4% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of METRONIDAZOLE 250 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for METRONIDAZOLE 250 MG TABLET, manufactured by Teva Pharmaceuticals USA Inc., is $0.1007 per EA (NDC 50111033302), effective Jun 24, 2026.
How has the price of METRONIDAZOLE 250 MG TABLET changed over time?
Over the history we have for it, the NADAC for METRONIDAZOLE 250 MG TABLET has declined 63.7%. It has been tracked across 657 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for METRONIDAZOLE 250 MG TABLET?
Since Nov 28, 2013, the NADAC for METRONIDAZOLE 250 MG TABLET has ranged from a low of $0.0623 (Dec 17, 2025) to a high of $0.2872 (Mar 12, 2014), with a median of $0.1506 per EA.
Are there cheaper alternatives to METRONIDAZOLE 250 MG TABLET?
Yes. 9 NADAC-published products share the same active ingredient, strength, and dosage form. The lowest-priced option, METRONIDAZOLE 250 MG TABLET, is $0.0970 per EA — about 4% below METRONIDAZOLE 250 MG TABLET.
Who manufactures METRONIDAZOLE 250 MG TABLET?
METRONIDAZOLE 250 MG TABLET (NDC 50111033302) is labeled by Teva Pharmaceuticals USA Inc., and CMS classifies it as a generic product.
Related Drugs
Same classification